Allgemein
16. June 2025 / 15. June 2025 by ohempel | Leave a Comment
dk Life Science Communications is delighted to welcome another new customer: The pharmaceutical company ROVI, manufacturer of the innovative drug Okedi® for the treatment of schizophrenia, is relying on the expertise of the Frankfurt-based healthcare specialists.
Read more »
